- Home
- LGVN vs NMTC Comparison
LGVN vs NMTC Comparison
Compare LGVN & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- NMTC
- Stock Information
- Founded
- LGVN 2014
- NMTC 2009
- Country
- LGVN United States
- NMTC United States
- Employees
- LGVN N/A
- NMTC N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- NMTC Medical/Dental Instruments
- Sector
- LGVN Health Care
- NMTC Health Care
- Exchange
- LGVN Nasdaq
- NMTC Nasdaq
- Market Cap
- LGVN 25.2M
- NMTC 21.0M
- IPO Year
- LGVN 2021
- NMTC N/A
- Fundamental
- Price
- LGVN $1.56
- NMTC $1.15
- Analyst Decision
- LGVN Strong Buy
- NMTC
- Analyst Count
- LGVN 3
- NMTC 0
- Target Price
- LGVN $8.67
- NMTC N/A
- AVG Volume (30 Days)
- LGVN 161.2K
- NMTC 248.1K
- Earning Date
- LGVN 02-28-2025
- NMTC 02-12-2025
- Dividend Yield
- LGVN N/A
- NMTC N/A
- EPS Growth
- LGVN N/A
- NMTC N/A
- EPS
- LGVN N/A
- NMTC N/A
- Revenue
- LGVN $1,852,000.00
- NMTC $5,749,521.00
- Revenue This Year
- LGVN $208.32
- NMTC $292.88
- Revenue Next Year
- LGVN $43.96
- NMTC N/A
- P/E Ratio
- LGVN N/A
- NMTC N/A
- Revenue Growth
- LGVN 141.46
- NMTC 104.21
- 52 Week Low
- LGVN $0.77
- NMTC $0.55
- 52 Week High
- LGVN $6.40
- NMTC $1.50
- Technical
- Relative Strength Index (RSI)
- LGVN 45.58
- NMTC 55.15
- Support Level
- LGVN $1.53
- NMTC $1.00
- Resistance Level
- LGVN $1.71
- NMTC $1.25
- Average True Range (ATR)
- LGVN 0.13
- NMTC 0.11
- MACD
- LGVN 0.02
- NMTC -0.00
- Stochastic Oscillator
- LGVN 38.30
- NMTC 64.66
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.